The GIP receptor activation improves insulin sensitivity in ways that GLP-1-only medications cannot fully replicate
A genetic association study reveals the relationship between the oral microbiome and anxiety and depression symptoms
Flexibility for buprenorphine prescribing for opioid use disorder The association called for an elimination of buprenorphine treatment dose limits for patients with opioid use disorder, arguing that the nations worsening opioid overdose epidemic necessitates prescribing flexibility
Published preclinical research has examined BPC-157 in experimental systems involving nitric oxide signalling, nitric oxide synthase activity, vascular endothelial growth factor pathways, fibroblast migration, inflammatory signalling and gastrointestinal mucosal biology
The obesity trial showed weight reductions of up to 14.7% at 36 weeks with the 45 mg dose, while the diabetes trial demonstrated HbA1c reductions of up to 2.1 percentage points and weight loss of up to 10.1 kg at 26 weeks
Myers PR, Minor Jr RL, Guerra Jr R, Bates JN, Harrison DG